| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5990176 | ABBVIE | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jan, 2017
(7 years ago) | |
| US6444859 | ABBVIE | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jan, 2017
(7 years ago) | |
| US6288127 | ABBVIE | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jan, 2017
(7 years ago) | |
|
US6444859 (Pediatric) | ABBVIE | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jul, 2017
(6 years ago) | |
|
US6288127 (Pediatric) | ABBVIE | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jul, 2017
(6 years ago) | |
|
US5990176 (Pediatric) | ABBVIE | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jul, 2017
(6 years ago) | |
| US6074668 | ABBVIE | Container for an inhalation anesthetic |
Jan, 2018
(6 years ago) | |
|
US6074668 (Pediatric) | ABBVIE | Container for an inhalation anesthetic |
Jul, 2018
(5 years ago) | |
Ultane is owned by Abbvie.
Ultane contains Sevoflurane.
Ultane has a total of 8 drug patents out of which 8 drug patents have expired.
Expired drug patents of Ultane are:
- US5990176
- US6444859
- US6288127
- US6444859*PED
- US6288127*PED
- US5990176*PED
- US6074668
- US6074668*PED
Ultane was authorised for market use on 07 June, 1995.
Ultane is available in liquid;inhalation dosage forms.
The generics of Ultane are possible to be released after 09 July, 2018.
Drugs and Companies using SEVOFLURANE ingredient
Market Authorisation Date: 07 June, 1995
Treatment: NA
Dosage: LIQUID;INHALATION
How can I launch a generic of ULTANE before it's drug patent expiration?
More Information on Dosage
ULTANE family patents
